News

By Dave Muoio August 24, 2018
23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports. While the raw data will remain available to clinical research partners such as GlaxoSmithKline, which invested $300 million this year to gain access to the genetic testing startup’s DNA database for drug...
By MobiHealthNews August 24, 2018
It's become an annual tradition for MobiHealthNews to parse Inc. Magazine's Inc 5,000 list of fastest growing companies in America, calling out the digital health and health tech companies that made the list. We found more companies than ever on this year's list, some you'll recognize and some you may not.   While MobiHealthNews doesn’t generally report on awards, we make an exception for Inc...
By Jonah Comstock August 23, 2018
Evidation Health is teaming up with Tidepool to launch a connected device-powered study of nocturnal hypoglycemic events in people with Type 1 diabetes.  The research is novel in that connected devices — including Dexcom continuous glucose monitors, an Emfit sleep monitor, and a WHOOP activity tracker — will allow researchers to access data about overnight low blood sugar events that previously...
By Dave Muoio August 23, 2018
Psychiatry has long stood as one of the more subjective areas of care, but new technologies and large-scale data generation and analysis may offer a more quantifiable approach to mental health treatment. In a recently published perspective, a group of Verily researchers and Former FDA Commissioner Dr. Robert Califf called for the psychiatric field to embrace digital sensors and the data sciences...

Credit: FDA.gov

By Jonah Comstock August 23, 2018
Online patient community PatientsLikeMe, which connects patients with different symptoms and conditions and collects patients' voluntarily submitted data for research, has teamed up with the FDA on a research study that could point the way toward a new channel for patient-generated health data for the agency. The study was recently published in the Journal of Medical Internet Research. Right now...
By Dave Muoio August 23, 2018
Dthera Sciences, a San Diego-based developer of clinical and consumer digital therapeutics for individuals with neurodegenerative conditions, announced today that its development stage intervention, DTHR-ALZ, has been granted Breakthrough Device designation by the FDA. As laid out in the 21st Century Cures Act, the Breakthrough Devices Program looks to streamline new medical technologies that...
a screensnap of Do No Harm trailer about doctor burnout

The panel will include a discussion with ‘Do No Harm’ documentary filmmaker Robyn Simon. Credit: Screen snap of film Do No Harm

By Jonah Comstock August 23, 2018
Eight years ago, Eliza CEO Alex Drane came up with the idea for “The Unmentionables,” an annual panel at Health 2.0 where participants would address difficult but important topics in healthcare. “Her bullet point was that there are things in healthcare that drive health outcomes that we don’t mention,” Health 2.0 cofounder and CEO Indu Subaiya told MobiHealthNews. “She started with topics like...
Omkar Kulkarni, CIO at Children's Hospital Los Angeles

Omkar Kulkarni, CIO at Children's Hospital Los Angeles, will be speaking at the Health 2.0 Conference in Santa Clara Sept. 16.

By Dave Muoio August 23, 2018
From digital therapeutics to virtual care and artificial intelligence, there are a number of novel advancements in healthcare technology offering providers an opportunity to revamp care for the better. But talking about healthcare innovation is easy — it’s the deployment and adoption that often trips up larger healthcare providers. Omkar Kulkarni, Children’s Hospital Los Angeles’ recently...
By Laura Lovett August 22, 2018
Smartphone and computer cameras have opened up new possibilities for dermatology: there is now a whole field dedicated to the world of teledermatology, and a plethora of companies sprouting up for both physician and patient-facing dermatology apps and platforms. But despite early promise, not all of these looking to strike it big in the smartphone dermatology market stuck around for the long haul...

Editor's Pick